Cargando…

1108. Evaluation of Vancomycin Dosing in Adolescents

BACKGROUND: Pediatric vancomycin dosing varies based on age and renal function. Recent literature suggests previously recommended doses of 45-60 mg/kg/day may be insufficient to achieve an AUC:MIC ratio of 400-600 mg-hr/L and higher doses of at least 60 mg/kg/day may be required. However, data to gu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Weaver, Ashley I, Wilson, Genene A, Belarski, Emily, Nelson, Allison, Kumar, Madan, Bhagat, Palak
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Poster Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8644511/ http://dx.doi.org/10.1093/ofid/ofab466.1302

Ejemplares similares

1314. Neonatal Serum Gentamicin Concentrations following Maternal Once-daily Gentamicin Dosing
por: Wilson, Genene A, et al.
Publicado: (2020)

1552. Correlation Between Vancomycin Serum Trough Concentrations and Area Under the Curve in Pediatric Patients
por: Weaver, Krista, et al.
Publicado: (2019)

1151. Clinical Characteristics of Persistent Staph Aureus Bacteremia in Children
por: Venturelli, Nicholas, et al.
Publicado: (2021)

741. Assessing the Concordance of MRSA Carriage Screening with MRSA Infections
por: Mannheim, Jonathan, et al.
Publicado: (2023)

1108. Transplantation and Immigration: Comparing Infectious Complications Between Foreign-born vs. U.S.-born Kidney Transplant Recipients in Minnesota
por: Espinoza, Eloy E Ordaya, et al.
Publicado: (2020)

992. Rethinking the 28-day HIV nPEP Dispensing Practice: A Pediatric ID Clinic Analysis
por: Zhang, David, et al.
Publicado: (2020)

1346. Implementation of a Multidisciplinary 48 Hour Antibiotic Timeout in a Pediatric Population
por: Konold, Victoria, et al.
Publicado: (2020)

1108. Diagnostic Yield of the BioFire FilmArray Gastrointestinal Panel in Hospitalized Children at an Academic Children’s Center
por: Madigan, Theresa, et al.
Publicado: (2018)

418. Evaluation of β-d-Glucan (BG) and Galactomannan (GM) Detection Assays in the Diagnosis of Invasive Fungal Infections in High-Risk Pediatric Cancer Patients
por: Alali, Muayad, et al.
Publicado: (2018)

1102. Evaluation of Vancomycin Accumulation in Patients with Obesity
por: Assadoon, Maha, et al.
Publicado: (2021)

227. Evaluation of Empiric Vancomycin Utilization at 72 Hours Post Admission: is De-escalation of Vancomycin Appropriate?
por: Naderi, Mandana, et al.
Publicado: (2020)

1091. Validation of an Allometrically Scaled Body Weight Equation to Predict Vancomycin Clearance and Guide 24-Hour Vancomycin AUC Dosing in Obese Patients
por: Footer, Brent, et al.
Publicado: (2021)

1107. Vancomycin AUC Dosing: Is One Concentration in the Hand Worth Two in the Bush?
por: Spivey, Justin, et al.
Publicado: (2021)

609. Implementation of Bayesian Software for Vancomycin Dosing Integrated into an Electronic Medical Record
por: Jantrakul, Nicholas A, et al.
Publicado: (2021)

1327. Vancomycin Dosing by AUC(24)/MIC in Comparison to Traditional Trough Dosing in Office Infusion Centers (OICs)
por: Luu, Quyen, et al.
Publicado: (2020)

1096. Evaluation of Vancomycin Pharmacokinetics in Intravenous Drug Users
por: Weihs, Sayo, et al.
Publicado: (2021)

P1108: HIGH COMPLETE RESPONSE RATE FOLLOWING POINT-OF-CARE ANTI CD19 CAR T-CELL THERAPY IN PATIENTS WITH RELAPSED/REFRACTORY FOLLICULAR LYMPHOMA
por: Fried, S., et al.
Publicado: (2022)

1618. Assessing and Improving Accurate Diagnosis and Reporting of Congenital Syphilis in a Tertiary Care Children's Hospital
por: Flores, John, et al.
Publicado: (2023)

1571. Evaluation of a Single Post First Dose Vancomycin Level to Achieve a Goal Vancomycin AUC
por: Hurley, Evan, et al.
Publicado: (2019)

Tu1108: INTERVAL CANCERS IN PATIENTS WITH HEREDITARY GASTROINTESTINAL SYNDROMES AFTER ONE YEAR OF THE SARS-COV-2 PANDEMIC
por: Barchi, Alberto, et al.
Publicado: (2022)

192. The Use of Area Under the Curve to Determine Therapeutic Vancomycin Dosing in Skin and Soft Tissue Infections
por: Dea, Lauren, et al.
Publicado: (2020)

1090. Does calculation method matter for targeting vancomycin AUC?
por: Chang, Jack, et al.
Publicado: (2021)

1572. Evaluation of Vancomycin Levels Following Weight-Based Pre-operative and Re-warming Vancomycin Dosing in Cardiac Surgery
por: Ruggero, Michael, et al.
Publicado: (2019)

1300. ACOG Committee Opinion #797 and the Dose of Intrapartum Vancomycin: a Potential Danger to Mother and Newborn Alike
por: Farkas, Andras, et al.
Publicado: (2020)

The CDC42 effector protein MRCKβ autophosphorylates on Threonine 1108
por: Unbekandt, Mathieu, et al.
Publicado: (2019)

1108. Impact of Implementing a Urine Culture Order Set on Antibiotic Utilization and Rates of Catheter-Associated Urinary Tract Infections in an Urban Academic Medical Center
por: Alnafoosi, Zainab, et al.
Publicado: (2019)

P1108: EFFICACY OF PIRTOBRUTINIB, A HIGHLY SELECTIVE, NON-COVALENT (REVERSIBLE) BTK INHIBITOR IN RELAPSED/REFRACTORY WALDENSTRÖM MACROGLOBULINEMIA: RESULTS FROM THE PHASE 1/2 BRUIN STUDY
por: Scarfò, Lydia, et al.
Publicado: (2023)

An Evaluation of Initial Vancomycin Dosing in Infants, Children, and Adolescents
por: Broome, Laura, et al.
Publicado: (2011)

1039. Forty-eight-hour Antibiotic Time-out: Impact on Antibiotic Duration and Clinical Outcomes
por: Pettit, Natasha N, et al.
Publicado: (2019)

141. Rapid Reduction in Concomitant Vancomycin and Piperacillin-tazobactam Use: A Model for Future Antimicrobial Stewardship Interventions
por: Kimball, Joanna, et al.
Publicado: (2020)

881. Efficacy of Antibiotic Prophylaxis with Vancomycin in Cardiothoracic Surgery
por: Cooper, Margaret, et al.
Publicado: (2020)

1329. Vancomycin Therapeutic Drug Monitoring: How to hit the Curve
por: Vala, Michael, et al.
Publicado: (2020)

1110. In Vivo Pharmacodynamics of Vancomycin Against Staphylococci in Young Infants
por: Gwee, Amanda, et al.
Publicado: (2021)

1108. Severity of Illness among Adults Hospitalized with Respiratory Syncytial Virus Compared with COVID-19 and Influenza — IVY Network, 25 Hospitals, 20 U.S. States, January 31, 2022 – April 11, 2023
por: Yuengling, Katharine, et al.
Publicado: (2023)

1575. Vancomycin Loading Doses and Nephrotoxicity on Medicine Teaching Services
por: Wagner, Phillip, et al.
Publicado: (2019)

1611. Evaluating Clinical Outcomes and Efficacy of Daptomycin in Combination with a Beta-Lactam for the Treatment of Vancomycin-Resistant Enterococcus (VRE) Bacteremia
por: Irusta, Nerea, et al.
Publicado: (2020)

234. Dalbavancin versus Outpatient Parenteral Antimicrobial Therapy with Vancomycin for Treatment of Bone and Joint Infections in a Veteran Population
por: Gibbons, Emily A, et al.
Publicado: (2021)

1354. Reducing vancomycin utilization rate in a level 4 NICU
por: Chang, Millie R, et al.
Publicado: (2020)

P17 Vancomycin therapeutic drug monitoring—a call for change?
por: Payne, Lara, et al.
Publicado: (2022)

1239. Ceftaroline versus Vancomycin as First-Line Therapy for MRSA Bacteremia
por: Kamath, Meghan, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_j4vgt8fp694k5lkra0d1slalvs